Press Release
Sugar Defender Explained: 2025 Update on Natural Glucose Management Through Lifestyle and Supplementation
As blood sugar support becomes a top wellness priority in 2025, this comprehensive breakdown explores Sugar Defender's plant-based formula, usage protocols, and integration strategies for sustainable glucose management. Read More
Press Release
2025's Top-Rated Claims Management RCM Software Vendors Announced at HFMA ANI by Black Book
Rankings unveiled at HFMA Annual National Institute in Denver spotlight leading software solutions for Clearinghouse, Denial Management, and Claim Adjudication across hospitals and physician organizations Read More
Press Release
Ereforce Offers Structured Supplementation Strategy for Energy, Hormonal Balance & Stamina Support
Now available in 3-, 6-, and 12-month plans, Ereforce combines eight traditional botanicals - including Ginseng, Tribulus, and Saw Palmetto - in a GMP-certified formula designed to support male vitality, circulation, and wellness integration in 2025. Read More
Press Release
American Firm Hydro-Link and Mitrelli Partner on a $1.5 Billion Investment for a Critical African Power Transmission Line
New 1,150km transmission line proposes to link Angola and the DRC HYDRO-LINK and Mitrelli join forces to deliver cross-border clean energy U.S. investment to secure DRC critical mineral and rare earth production Read More
Press Release
From Rural Hospitals to Academic Health Systems: 2025's Best End-to-End RCM Vendors Ranked by Client Satisfaction & Performance, Black Book User Survey
Healthcare Finance Leaders Identify Top Software Solutions Across U.S. Hospital Segments Based on Real-World Results, ROI, and Financial Outcomes Read More
Press Release
MindQuell Offers Natural Plant-Based Memory Support Formula With Bacopa, Ginkgo and Lion's Mane in 2025
New Liquid Nootropic Supplement Combines Clinically Studied Botanicals to Address Brain Fog, Enhance Focus, and Support Cognitive Health in Adults Seeking Natural Memory Solutions Read More
Press Release
International Demand Surges for U.S. Revenue Cycle Management Solutions Amid Rapid Private Insurance Expansion, Black Book Reports
U.S. Vendors Accelerate Global Growth, Addressing Increasingly Complex Private Healthcare Markets in Canada, Australia, UK, Germany, and Beyond; Updated 2025 Analysis Released at HFMA ANI Conference Read More
Press Release
Jaguar Health Provides Updates on Orphan Disease Intestinal Failure Development Program for Crofelemer
Enrollment in company's first-of-its-kind placebo-controlled Phase 2 study to evaluate the efficacy of crofelemer for microvillus inclusion disease (MVID) in pediatric patients has reached approximately 25% As recently announced, initial proof-of-concept results of the ongoing investigator-initiated trial (IIT) show crofelemer reduced the required total parenteral nutrition in patients with intestinal failure due to MVID and short bowel syndrome by up to 27% and 12.5% respectively; data from the third patient enrolled is expected Company strategy: Seek business development partnerships for license to develop and commercialize Jaguar's intestinal failure products, resulting in non-dilutive funding for Jaguar Read More
Press Release
Aytu BioPharma Expands and Extends Lending Agreement with Eclipse Following Agreement to Commercialize First-in-Class Antidepressant EXXUA(TM)
Term loan maturity extended by 12 months to June 2029 Principal balance on term loan expanded to $13.0 million from $11.1 million currently Expanded revolving line of credit facility by $1.5 million Expanded facilities allow for added working capital flexibility as commercial launch of EXXUA is anticipated to occur in the fourth calendar quarter of 2025 Read More
Press Release
Jerash Holdings Reports Financial Results for Fiscal 2025 Fourth Quarter and Full Year
-- Record annual revenue of $145.8 million, up 24.4 percent from prior year -- Fiscal Fourth Quarter Highlights Gross profit increases to $5.2 million from $1.5 million a year ago. Gross margin increases to 17.9 percent from 7.0 percent a year ago. Revenue rises 35.6 percent to $29.3 million, despite approximately $3-4 million of shipments deferred to first quarter of fiscal 2026, due to delays at Haifa port. Read More
Press Release
DEA Blocks MMJ FDA Cannabis Research While Tribal Marijuana Transit Networks Operate in N.C. Unchecked
Watch the Senate hearing: https://dai.ly/x9j0le4 Despite MMJ's full regulatory compliance and orphan drug status from the FDA, its DEA manufacturing registration (GROW MARIJUANA) remains stonewalled inside a DEA administrative court system now deemed unconstitutional under Axon and Jarkesy. Meanwhile, tribal transit networks face virtually no enforcement-exposing a hypocritical and dangerous DEA double standard. Read More
Press Release
